HLA-A and neoplasm: An HLA allotype-specific search for frequent tumor-exclusive peptides within the OvCa and CLL cohort further revealed HLA-A*02:01 tumor-exclusive peptides with frequencies of up to 41.7%, and 54.5%, respectively (online supplemental figure 11a-d).